ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy
Rodionov, Roman N., Heinrich, Annett, Brilloff, Silke, Jarzebska, Natalia, Martens-Lobenhoffer, Jens, Bode-Böger, Stefanie M., Todorov, Vladimir T., Hugo, Christian P.M., Weiss, Norbert, Hohenstein, BLanguage:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/j.atherosclerosissup.2017.05.031
Date:
June, 2017
File:
PDF, 477 KB
english, 2017